Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clotrimazole versus combination antifungal-antibiotic-corticosteroid cream for otomycosis
TCTR20250225001Phase 0Recruiting
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Oct 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 0, randomised, open-label trial of clotrimazole, nystatin, neomycin, gramicidin and triamcinolone acetonide in otomycosis (2 arms), sponsored by Faculty of Medicine, Chiang Mai University. Primary endpoint: Complete endoscopic response rate. Started Oct 2023; status: recruiting.
02
Drugs
clotrimazolenystatinneomycingramicidintriamcinolone acetonide
03
Conditions
otomycosis
Beyond the preview
Go deeper on TCTR20250225001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250225001.